| Lipids Management |
1 |
1 |
| Statins |
0 |
0.99 |
| Adverse Effects |
0 |
0.12 |
| Patient Safety |
0 |
0.12 |
| Cardiovascular Risk Management |
0 |
0.07 |
| PCSK9 |
0 |
0.07 |
| Generics |
0 |
0.04 |
| Coronary Artery Disease (CAD) |
0 |
0.03 |
| LDL Cholesterol |
0 |
0.03 |
| Adherence |
0 |
0.02 |
| Cardiovascular disease |
0 |
0.02 |
| Cerebrovascular Accident |
0 |
0.02 |
| Clinical Guidelines |
0 |
0.02 |
| Lipoproteins |
0 |
0.02 |
| Myocardial Infarction (MI) |
0 |
0.02 |
| Myocardial Infarction (MI) History |
0 |
0.02 |
| Patient History |
0 |
0.02 |
| Pharmacodynamics |
0 |
0.02 |
| Stress |
0 |
0.02 |